Human TRANK1 (aa 905-990) Control Fragment Recombinant Protein | Invitrogen RP-96430 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

protein

product name :

Human TRANK1 (aa 905-990) Control Fragment Recombinant Protein

catalog :

RP-96430

quantity :

100 uL

price :

US 259.00

product information

Product Type :

Protein

Product Name :

Human TRANK1 (aa 905-990) Control Fragment Recombinant Protein

Catalog # :

RP-96430

Quantity :

100 uL

Price :

US 259.00

Clonality :

Recombinant

Purity :

purified

Reactivity :

Human

Applications :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Species :

Human

Storage :

-20 C, Avoid Freeze/Thaw Cycles

Description :

The TRANK1 gene encodes the tetratricopeptide repeat and ankyrin repeat containing 1 protein, which has been associated with neurodevelopmental and psychiatric conditions, particularly bipolar disorder and schizophrenia. Located on chromosome 9, this gene contains both tetratricopeptide repeats and ankyrin repeats, which contribute to protein-protein interactions and structural stability. TRANK1 is thought to possibly participate in cellular functions related to brain development and synaptic transmission, impacting neuronal signaling and cognitive processes. Genetic studies have identified variations in the TRANK1 gene that may alter its expression, influencing susceptibility to bipolar disorder by modulating pathways related to neurotransmitter regulation and neuroplasticity. The specific mechanisms by which TRANK1 influences psychiatric disorders remain under investigation, but it is hypothesized that TRANK1's interaction with other proteins involved in signal transduction could be pivotal. Given its potential linkage to complex neurological disorders, TRANK1 serves as a significant focal point for studies aiming to understand the genetic basis of these conditions and develop targeted interventions.

Format :

Liquid

Applications w/Dilutions :

Blocking Assay: Assay-dependent, Control: Assay-dependent

Aliases :

KIAA0342; LBA1; Lupus brain antigen 1 homolog; tetratricopeptide repeat and ankyrin repeat containing 1; TPR and ankyrin repeat-containing protein 1; TRANK1